Rates and impact of hepatitis on human immunodeficiency virus infection in a large African cohort

World Journal of Gastroenterology

Volumn 19, Issue 10, 2013, Pages 1602-1610

  Gwamzhi Ladep, Nimzing ^a   Aladi Agaba, Patricia ^b   Agbaji, Oche ^b   Muazu, Auwal ^b   Ugoagwu, Placid ^b   Imade, Godwin ^b   Cooke, Graham ^a   McCormack, Sheena ^c   Taylor Robinson, Simon David ^a   Idoko, John ^b,d   Kanki, Phyllis ^e  

^a ST MARY S HOSPITAL   (United Kingdom)

^b UNIVERSITY OF JOS   (Nigeria)

^c MRC CLINICAL TRIALS UNIT   (United Kingdom)

^d NATIONAL AGENCY FOR THE CONTROL OF AIDS   (Nigeria)

^e HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Africa; Hepatitis b; Hepatitis c; Human immunodeficiency virus; Liver disease

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; HEPATITIS C ANTIBODY; VIRUS RNA;

ADOLESCENT; ADULT; AFRICA; ARTICLE; CD4 LYMPHOCYTE COUNT; CONTROLLED STUDY; ENZYME IMMUNOASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; FOLLOW UP; HEPATITIS B; HEPATITIS C; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIVER DISEASE; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; PREVALENCE; RETROSPECTIVE STUDY; SCREENING; SEROLOGY; VIRUS LOAD;

EID: 84875329055     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v19.i10.1602     Document Type: Article

References (33)

1. Adekunle AE, Oladimeji AA, Temi AP, Adeseye AI, Akinyeye OA, Taiwo RH. Baseline CD4+ T lymphocyte cell counts, hepatitis B and C viruses seropositivity in adults with Human Immunodeficiency Virus infection at a tertiary hospital in Nigeria. Pan Afr Med J 2011; 9: 6 [PMID: 22145054]
2. Adesina O, Oladokun A, Akinyemi O, Adedokun B, Awolude O, Odaibo G, Olaleye D, Adewole I. Human immuno-deficiency virus and hepatitis B virus coinfection in pregnancy at the University College Hospital, Ibadan. Afr J Med Med Sci 2010; 39: 305-310 [PMID: 21735996]
3. Forbi JC, Gabadi S, Alabi R, Iperepolu HO, Pam CR, Entonu PE, Agwale SM. The role of triple infection with hepatitis B virus, hepatitis C virus, and human immunodeficiency virus (HIV) type-1 on CD4+ lymphocyte levels in the highly HIV infected population of North-Central Nigeria. Mem Inst Oswaldo Cruz 2007; 102: 535-537 [PMID: 17612776 DOI: 10.1590/S0074-02762007005000025]
4. Ladep NG, Taylor-Robinson SD. Management of liver disease in Nigeria. Clin Med 2007; 7: 439-441 [PMID: 17990704]
5. Kiertiburanakul S, Chotiprasitsakul D, Atamasirikul K, Sungkanuparph S. Late and low compliance with hepatitis B serology screening among HIV-infected patients in a resource-limited setting: an issue to improve HIV care. Curr HIV Res 2011; 9: 54-60 [PMID: 21198430 DOI: 10.2174/15701 6211794582669]
6. Sungkanuparph S, Wongprasit P, Manosuthi W, Atamasirikul K. Compliance with hepatitis B and hepatitis C virus infection screening among HIV-1 infected patients in a resource-limited setting. Southeast Asian J Trop Med Public Health 2008; 39: 863-866 [PMID: 19058581]
7. Buskin SE, Barash EA, Scott JD, Aboulafia DM, Wood RW. Hepatitis B and C infection and liver disease trends among human immunodeficiency virus-infected individuals. World J Gastroenterol 2011; 17: 1807-1816 [PMID: 21528052 DOI: 10.3748/wjg.v17.i14.1807]
8. Kouanfack C, Aghokeng AF, Mondain AM, Bourgeois A, Kenfack A, Mpoudi-Ngolé E, Ducos J, Delaporte E, Laurent C. Lamivudine-resistant HBV infection in HIV-positive patients receiving antiretroviral therapy in a public routine clinic in Cameroon. Antivir Ther 2012; 17: 321-326 [PMID: 22290198 DOI: 10.3851/IMP1911]
9. Stewart B, Jobarteh ML, Sarge-Njie R, Alabi A, de Silva T, Peterson K, Peterson I, Whittle H, Rowland-Jones S, Jaye A, Cotten M, Mendy M. Emergence of HBV resistance to lamivudine (3TC) in HIV/HBV co-infected patients in The Gambia, West Africa. BMC Res Notes 2011; 4: 561 [PMID: 22195774 DOI: 10.1186/1756-0500-4-561]
10. Benhamou Y, Fleury H, Trimoulet P, Pellegrin I, Urbinelli R, Katlama C, Rozenbaum W, Le Teuff G, Trylesinski A, Piketty C. Anti-hepatitis B virus efficacy of tenofovir disoproxil fumarate in HIV-infected patients. Hepatology 2006; 43: 548-555 [PMID: 16496322 DOI: 10.1002/hep.21055]
11. Agaba PA, Digin E, Makai R, Apena L, Agbaji OO, Idoko JA, Murphy R, Kanki P. Clinical characteristics and predictors of mortality in hospitalized HIV-infected Nigerians. J Infect Dev Ctries 2011; 5: 377-382 [PMID: 21628815 DOI: 10.3855/jidc.1096]
12. Chun HM, Fieberg AM, Hullsiek KH, Lifson AR, Crum- Cianflone NF, Weintrob AC, Ganesan A, Barthel RV, Bradley WP, Agan BK, Landrum ML. Epidemiology of Hepatitis B virus infection in a US cohort of HIV-infected individuals during the past 20 years. Clin Infect Dis 2010; 50: 426-436 [PMID: 20047484 DOI: 10.1086/649885]
13. Sirisena ND, Njoku MO, Idoko JA, Isamade E, Barau C, Jelpe D, Zamani A, Otowo S. Carriage rate of hepatitis-B surface antigen (HBsAg) in an urban community in Jos, Plateau State, Nigeria. Niger Postgrad Med J 2002; 9: 7-10 [PMID: 11932753]
14. Uneke CJ, Ogbu O, Inyama PU, Anyanwu GI, Njoku MO, Idoko JH. Prevalence of hepatitis-B surface antigen among blood donors and human immunodeficiency virus-infected patients in Jos, Nigeria. Mem Inst Oswaldo Cruz 2005; 100: 13-16 [PMID: 15867956 DOI: 10.1590/S0074-02762005000 100002]
15. Jombo GT, Egah DZ, Banwat EB. Hepatitis B virus infection in a rural settlement of northern Nigeria. Niger J Med 2005; 14: 425-428 [PMID: 16353707]
16. Egah DZ, Banwat EB, Audu ES, Iya D, Mandong BM, Anele AA, Gomwalk NE. Hepatitis B surface antigen, hepatitis C and HIV antibodies in a low-risk blood donor group, Nigeria. East Mediterr Health J 2007; 13: 961-966 [PMID: 17955779]
17. Lesi OA, Kehinde MO, Oguh DN, Amira CO. Hepatitis B and C virus infection in Nigerian patients with HIV/AIDS. Niger Postgrad Med J 2007; 14: 129-133 [PMID: 17599111]
18. Puoti M, Manno D, Nasta P, Carosi G. Hepatitis B virus and HIV coinfection in low-income countries: unmet needs. Clin Infect Dis 2008; 46: 367-369 [PMID: 18171305 DOI: 10.1086/ 525532]
19. Simonsen L, Kane A, Lloyd J, Zaffran M, Kane M. Unsafe injections in the developing world and transmission of bloodborne pathogens: a review. Bull World Health Organ 1999; 77: 789-800 [PMID: 10593026]
20. Engels EA, Biggar RJ, Hall HI, Cross H, Crutchfield A, Finch JL, Grigg R, Hylton T, Pawlish KS, McNeel TS, Goedert JJ. Cancer risk in people infected with human immunodeficiency virus in the United States. Int J Cancer 2008; 123: 187-194 [PMID: 18435450 DOI: 10.1002/ijc.23487]
21. Shiels MS, Cole SR, Kirk GD, Poole C. A meta-analysis of the incidence of non-AIDS cancers in HIV-infected individuals. J Acquir Immune Defic Syndr 2009; 52: 611-622 [PMID: 19770804 DOI: 10.1097/QAI.0b013e3181b327ca]
22. Idoko J. A clinician's experience with the President's Emergency Plan for AIDS Relief in Nigeria: a transformative decade of hope. Health Aff (Millwood) 2012; 31: 1422-1428 [PMID: 22778331 DOI: 10.1377/hlthaff.2012.0349]
23. Idoko J, Meloni S, Muazu M, Nimzing L, Badung B, Hawkins C, Sankalé JL, Ekong E, Murphy R, Kanki P, Thio CL. Impact of hepatitis B virus infection on human immunodeficiency virus response to antiretroviral therapy in Nigeria. Clin Infect Dis 2009; 49: 1268-1273 [PMID: 19772386 DOI: 10.1086/605675]
24. Sheng WH, Chen MY, Hsieh SM, Hsiao CF, Wang JT, Hung CC, Chang SC. Impact of chronic hepatitis B virus (HBV) infection on outcomes of patients infected with HIV in an area where HBV infection is hyperendemic. Clin Infect Dis 2004; 38: 1471-1477 [PMID: 15156487 DOI: 10.1086/420744]
25. Law WP, Duncombe CJ, Mahanontharit A, Boyd MA, Ruxrungtham K, Lange JM, Phanuphak P, Cooper DA, Dore GJ. Impact of viral hepatitis co-infection on response to antiretroviral therapy and HIV disease progression in the HIVNAT cohort. AIDS 2004; 18: 1169-1177 [PMID: 15166532 DOI: 10.1097/00002030-200405210-00010]
26. Konopnicki D, Mocroft A, de Wit S, Antunes F, Ledergerber B, Katlama C, Zilmer K, Vella S, Kirk O, Lundgren JD. Hepatitis B and HIV: prevalence, AIDS progression, response to highly active antiretroviral therapy and increased mortality in the EuroSIDA cohort. AIDS 2005; 19: 593-601 [PMID: 15802978 DOI: 10.1097/01.aids.0000163936.99401.fe]
27. Hoffmann CJ, Charalambous S, Martin DJ, Innes C, Churchyard GJ, Chaisson RE, Grant AD, Fielding KL, Thio CL. Hepatitis B virus infection and response to antiretroviral therapy (ART) in a South African ART program. Clin Infect Dis 2008; 47: 1479-1485 [PMID: 18937580 DOI: 10.1086/593104]
28. Iser DM, Avihingsanon A, Wisedopas N, Thompson AJ, Boyd A, Matthews GV, Locarnini SA, Slavin J, Desmond PV, Lewin SR. Increased intrahepatic apoptosis but reduced immune activation in HIV-HBV co-infected patients with advanced immunosuppression. AIDS 2011; 25: 197-205 [PMID: 21076271 DOI: 10.1097/QAD.0b013e3283410ccb]
29. Dunn C, Peppa D, Khanna P, Nebbia G, Jones M, Brendish N, Lascar RM, Brown D, Gilson RJ, Tedder RJ, Dusheiko GM, Jacobs M, Klenerman P, Maini MK. Temporal analysis of early immune responses in patients with acute hepatitis B virus infection. Gastroenterology 2009; 137: 1289-1300 [PMID: 19591831 DOI: 10.1053/j.gastro.2009.06.054]
30. Zoutendijk R, Zaaijer HL, de Vries-Sluijs TE, Reijnders JG, Mulder JW, Kroon FP, Richter C, van der Eijk AA, Sonneveld MJ, Hansen BE, de Man RA, van der Ende ME, Janssen HL. Hepatitis B surface antigen declines and clearance during long-term tenofovir therapy in patients coinfected with HBV and HIV. J Infect Dis 2012; 206: 974-980 [PMID: 22782950]
31. You J, Sriplung H, Geater A, Chongsuvivatwong V, Zhuang L, Li YL, Lei H, Liu J, Chen HY, Tang BZ, Huang JH. Impact of viral replication inhibition by entecavir on peripheral T lymphocyte subpopulations in chronic hepatitis B patients. BMC Infect Dis 2008; 8: 123 [PMID: 18803883 DOI: 10.1186/1471-2334-8-123]
32. Hoffmann CJ, Seaberg EC, Young S, Witt MD, D'Acunto K, Phair J, Thio CL. Hepatitis B and long-term HIV outcomes in coinfected HAART recipients. AIDS 2009; 23: 1881-1889 [PMID: 19550291 DOI: 10.1097/QAD.0b013e32832e463a]
33. Sagoe KW, Agyei AA, Ziga F, Lartey M, Adiku TK, Seshi M, Arens MQ, Mingle JA. Prevalence and impact of hepatitis B and C virus co-infections in antiretroviral treatment naïve patients with HIV infection at a major treatment center in Ghana. J Med Virol 2012; 84: 6-10 [PMID: 22095533]